BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 222971)

  • 21. Risk of subsequent contralateral breast carcinoma in a population of patients with in-situ breast carcinoma.
    Webber BL; Heise H; Neifeld JP; Costa J
    Cancer; 1981 Jun; 47(12):2928-32. PubMed ID: 6266644
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Carcinoma of the male breast (our experience and a review of the literature)].
    Modena S; Massocco A; Trivisone M; Abrescia F; Montresor E; Girardi C
    Chir Ital; 1990; 42(1-2):27-35. PubMed ID: 1963817
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Management of cancer of the opposite breast following breast preservation.
    Sardi A; Facundus EC; Eckholdt GJ; McKinnon WM; Skenderis BS; Bolton JS
    Int Surg; 1992; 77(4):289-92. PubMed ID: 1336002
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Breast neoplasms. A 10-year material].
    Svennevig JL; Pedersen K
    Tidsskr Nor Laegeforen; 1974 Feb; 94(4):217-20. PubMed ID: 4362584
    [No Abstract]   [Full Text] [Related]  

  • 25. Multicentric and bilateral appearance of lobular carcinoma in situ of the breast.
    Anderson JA
    Acta Pathol Microbiol Scand A; 1974 Nov; 82(6):730-4. PubMed ID: 4374873
    [No Abstract]   [Full Text] [Related]  

  • 26. [Relation between dysplasias, benign breast tumors and cancer of the breast. Retrospective study in a group of 735 patients].
    Badellino F; Santoro L; Volterrani P; Trabucco A; Tardy A
    Cancro; 1974; 27(5):263-70. PubMed ID: 4376974
    [No Abstract]   [Full Text] [Related]  

  • 27. Regional differences in the incidence and treatment of carcinoma in situ of the breast.
    Choi WS; Parker BA; Pierce JP; Greenberg ER
    Cancer Epidemiol Biomarkers Prev; 1996 Apr; 5(4):317-20. PubMed ID: 8722225
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term follow-up of in situ carcinoma of the breast with special emphasis on clinging carcinoma.
    Eusebi V; Foschini MP; Cook MG; Berrino F; Azzopardi JG
    Semin Diagn Pathol; 1989 May; 6(2):165-73. PubMed ID: 2548274
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In situ ductal carcinoma of the breast--analysis of clinical presentation and outcome in 156 consecutive cases.
    Ciatto S; Grazzini G; Iossa A; Del Turco MR; Bravetti P; Cataliotti L; Cardona G; Bianchi S
    Eur J Surg Oncol; 1990 Jun; 16(3):220-4. PubMed ID: 2161353
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pure tubular breast carcinoma: a 34 year study of outcomes.
    Wagner TD; Wharton K; Donohue K; Sperl ML; Flaherty L; Jaggernauth W; Yap JC; Fernando SA; Landry JC; Yang GY
    Breast J; 2008; 14(5):512-3. PubMed ID: 18821938
    [No Abstract]   [Full Text] [Related]  

  • 31. Risk of subsequent invasive breast cancer after breast carcinoma in situ.
    Wärnberg F; Yuen J; Holmberg L
    Lancet; 2000 Feb; 355(9205):724-5. PubMed ID: 10703809
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sentinel node procedure is warranted in ductal carcinoma in situ with high risk of occult invasive carcinoma and microinvasive carcinoma treated by mastectomy.
    Tunon-de-Lara C; Giard S; Buttarelli M; Blanchot J; Classe JM; Baron M; Monnier B; Houvenaeghel G
    Breast J; 2008; 14(2):135-40. PubMed ID: 18315691
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ductal carcinoma in situ (DCIS) of the breast: evolving perspectives.
    Sakorafas GH; Tsiotou AG
    Cancer Treat Rev; 2000 Apr; 26(2):103-25. PubMed ID: 10772968
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Noninvasive breast cancer: Part 2. Lobular carcinoma in situ--incidence, presentation, guidelines to treatment.
    Swain SM
    Oncology (Williston Park); 1989 Mar; 3(3):35-40; discussion 40, 42, 44 passim. PubMed ID: 2561881
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk of invasive breast carcinoma among women diagnosed with ductal carcinoma in situ and lobular carcinoma in situ, 1988-2001.
    Li CI; Malone KE; Saltzman BS; Daling JR
    Cancer; 2006 May; 106(10):2104-12. PubMed ID: 16604564
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Carcinoma of the breast. Considerations on prognosis and therapy].
    Santangelo A; Di Guglielmo A; Turra G; Bertazzoni G; Morgutti L
    Minerva Ginecol; 1984 Oct; 36(10):577-81. PubMed ID: 6098867
    [No Abstract]   [Full Text] [Related]  

  • 37. The role of sentinel lymph node biopsy in the management of breast cancer.
    Khan A; Vohra P; Quinlan RF
    Indian J Pathol Microbiol; 2007 Apr; 50(2):261-9. PubMed ID: 17883042
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [In situ carcinomas of the breast: clinical features and therapeutic strategies].
    Attene F; Scognamillo F; Trignano E; Meloni GB; Rubino C; Trignano M
    Ann Ital Chir; 2006; 77(1):3-10; discussion 10-2. PubMed ID: 16910353
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Breast cancer--Duluth, Minnesota. A community analysis.
    Campaigne R
    Minn Med; 1983 Jun; 66(6):373, 375-6. PubMed ID: 6308413
    [No Abstract]   [Full Text] [Related]  

  • 40. Minimal breast cancer: advance or anachronism?
    Wolmark N
    Can J Surg; 1985 May; 28(3):252-5. PubMed ID: 2986808
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.